Products

d-Nav System
Hygieia
Endocrinology & Metabolic AI

See all 1 product →

About Hygieia

This program is designed to make insulin therapy easier and more effective for individuals with diabetes.

For physicians, Hygieia’s d-Nav program offers a system that automatically interprets data and independently provides insulin dose recommendations at the time of injection, reducing the need for frequent physician interventions. Studies have indicated that nearly 90% of d-Nav patients have shown improved A1C levels within 90 days without an increased risk of hypoglycemia. The company is also building a network of diabetes care centers and offers a d-Nav Clinical Partnership Program for endocrinology practices, aiming to improve patient outcomes and provide an added revenue stream.

Focus Areas

AI-powered insulin management digital therapeutics diabetes care glycemic control remote patient monitoring mobile health

Business Intelligence

TechnologyCloud-based technology, AI-powered insulin-titration algorithms, mobile application

What Physicians Need to Know

AI-Powered Insulin Management
Hygieia developed the d-Nav® Insulin Management Program, which is the first and only FDA-cleared AI-driven technology to automatically adjust insulin doses for people with type 2 diabetes. This technology aims to improve clinical outcomes and reduce healthcare costs.
Digital Therapeutics
Hygieia specializes in digital therapeutics for insulin therapy, offering solutions that make insulin management easier and more effective. Their d-Nav program provides autonomous insulin dose recommendations.
Diabetes Management
The company's core mission is to improve clinical outcomes, reduce healthcare costs, and enhance the quality of life for patients with diabetes through advanced digital tools and clinical support.
Patient Engagement
The d-Nav app allows patients to log glucose event data and receive recommended insulin doses directly, supporting active patient participation in their diabetes management.
Healthcare Analytics
Hygieia's cloud-based service leverages proprietary algorithms and individual blood glucose data to generate insulin dosage recommendations, indicating a strong foundation in healthcare analytics.
Medical Devices
The d-Nav program is an FDA-cleared medical device, specifically a prescription-only mobile app that aids in optimizing insulin doses.
Key Differentiators
Hygieia's primary differentiator is its FDA-cleared AI-driven technology that autonomously adjusts insulin doses, a function traditionally performed solely by physicians. Studies have shown nearly 90% of d-Nav patients improved A1C levels within 90 days without increased hypoglycemia risk.
Technology Stack
Hygieia's d-Nav Insulin Guidance Service uses cloud-based technology and proprietary insulin-titration algorithms. The system is designed to be compatible with existing clinical IT infrastructure.
Physician Tip

For physicians, Hygieia's d-Nav program offers a significant advantage by providing an FDA-cleared, AI-powered solution for autonomous insulin dose adjustments in type 2 diabetes patients. This can alleviate the burden of frequent manual dose titration, allowing physicians to focus on other aspects of patient care. The program has demonstrated improved A1C levels for patients, and new Category III CPT codes have been approved for autonomous insulin dose titration, which can facilitate reimbursement. The system supports all common insulin regimens and aims to improve patient outcomes with minimal hypoglycemia.

Hygieia's d-Nav app connects to glucose meters to collect relevant data, and its cloud-based architecture is designed for compatibility with existing clinical IT systems. This suggests a focus on seamless integration into current healthcare workflows.

Products by Hygieia

1 product in the directory

d-Nav System
Hygieia
Endocrinology & Metabolic AI

Videos

News, demos, and interviews about Hygieia.

Loading videos...

Videos load interactively. If none appear, search YouTube for Hygieia →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Hygieia offers the d-Nav® Insulin Guidance System, an AI-powered digital therapeutic that provides personalized insulin dose recommendations for people with type 2 diabetes. The system integrates with existing clinical workflows by allowing healthcare providers to remotely monitor patient progress and adjust treatment plans as needed, aiming to simplify insulin management and improve patient outcomes.
Hygieia's d-Nav® system aims to enhance patient engagement by providing individualized, real-time insulin dose adjustments, empowering patients to actively participate in their diabetes management. The system's ease of use and personalized guidance are designed to improve adherence by reducing the complexity and burden often associated with insulin therapy.
Hygieia's d-Nav® system has demonstrated significant improvements in glycemic control, with studies showing a reduction in A1C levels. The company can provide data on metrics such as time in range, reduction in hypoglycemic events, and overall patient satisfaction to illustrate the effectiveness and value of its AI-powered insulin management.
Hygieia's d-Nav® Insulin Guidance System is FDA-cleared, ensuring it meets rigorous safety and efficacy standards for medical devices. The company prioritizes data privacy and security through robust encryption protocols and adherence to HIPAA regulations, safeguarding sensitive patient information.
Hygieia's pricing model is designed to be accessible, often working through partnerships with health plans and providers to integrate the d-Nav® system into existing care pathways. The company provides comprehensive support for healthcare providers through training and ongoing clinical assistance, and for patients through user-friendly interfaces and dedicated customer service.
Hygieia is actively seeking partnerships with health systems, payers, and other digital health companies to expand the reach of its AI-powered insulin management solutions. The company demonstrates strong stability and a positive growth outlook, driven by the increasing demand for effective and personalized diabetes management tools.

Related Companies

CompuGroup Medical is a leading software and e-health provider for doctors, hospitals, community health centers, laboratories, and more. The company offers a comprehensive suite of solutions that support the entire patient journey, from online scheduling and digital intake to AI-powered electronic health record (EHR) documentation, e-prescribing, lab connectivity, telehealth, remote patient monitoring, and revenue cycle […]

AiHealth Clinic is a precision metabolic medicine practice and platform based in Bengaluru, India, specializing in diabetes and obesity care. It offers a continuous intelligence approach, moving beyond traditional three-month snapshots of metabolic health. The clinic utilizes continuous glucose monitoring (CGM), GLP-1/GIP therapies, and proprietary AI-driven scoring engines (MMIQ for metabolic health and BMIQ for […]

90Health offers a comprehensive digital solution for managing chronic diseases, aiming to address the significant financial burden these conditions place on the U.S. healthcare system. Their platform integrates AI-powered digital programs with human support to facilitate behavior change and improve patient outcomes. The solution includes access to evidence-based cognitive behavioral lessons designed to help patients […]

The SafeCare Group is an AI-driven healthcare technology company focused on enhancing healthcare outcomes by intelligently utilizing electronic medical record (EMR) data. Their SafeCare AI® platform, also known as SafeCare Applied Intelligence®, has been operational since 2016. It integrates intelligence capabilities to predict healthcare outcomes and identify opportunities to intervene, helping hospitals allocate limited clinical […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.